A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers

Acellular pertussis vaccines do not control pertussis. A new approach to offer protection to infants is necessary. BPZE1, a genetically modified Bordetella pertussis strain, was developed as a live attenuated nasal pertussis vaccine by genetically eliminating or detoxifying 3 toxins. We performed a...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 1; p. e83449
Main Authors Thorstensson, Rigmor, Trollfors, Birger, Al-Tawil, Nabil, Jahnmatz, Maja, Bergström, Jakob, Ljungman, Margaretha, Törner, Anna, Wehlin, Lena, Van Broekhoven, Annie, Bosman, Fons, Debrie, Anne-Sophie, Mielcarek, Nathalie, Locht, Camille
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 08.01.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…